Monsanto, Albaugh reach licensing agreement for glyphosate formulations

Monsanto Co. and Albaugh LLC announced Tuesday that both companies have entered into a royalty-beating license agreement that allows Albaugh to make and sell specific glyphosate formulations in the United States, Canada, and Europe.

“For years, Albaugh has been a valued partner in providing crop protection choices that help farmers,” Monsanto’s Vice President for Commercial Operations Mike Frank said. “These specific formulations offer many benefits to end-use customers, including improved efficacy, storage and handling properties – all important advancements as glyphosate remains the cornerstone of farmers’ diversified weed management programs.”

Allbaugh will immediately introduce its potassium glyphosate products in the U.S. and Canada, and initiate the registration process for future introductions in Europe. 

“We are pleased with this agreement and the opportunity to further strengthen Albaugh’s portfolio of glyphosate product offerings,” Albaugh Group CEO Kurt Pedersen Kaalund said.